Literature DB >> 17091451

[Expression of DPP4 gene in papillary thyroid carcinoma].

Joanna Ozóg1, Michał Jarzab, Agnieszka Pawlaczek, Małgorzata Oczko-Wojciechowska, Jan Włoch, Józef Roskosz, Elzbieta Gubała.   

Abstract

INTRODUCTION: DPP4 gene (dipeptidyl peptidase IV) is expressed in epithelial cells of many organs and cells of immune system. There is no expression of DPP4 in normal healthy thyroid, while it is highly expressed in papillary thyroid carcinoma (PTC), as shown by gene expression profiling. In this study we validated expression of DPP4 in papillary thyroid cancer and normal thyroid tissue and evaluated its usefulness for diagnostic purposes.
MATERIAL AND METHODS: The analysis was carried out on total RNA extracted from 102 PTCs and 77 normal thyroid fragments with use of Q-PCR reaction. Beta-glucuronidase was the reference gene.
RESULTS: We confirmed the distinct increase of DPP4 expression in papillary thyroid carcinoma. However, the ROC (relative operating characteristic) analysis revealed that the diagnostic efficiency of DPP4 estimation is limited.
CONCLUSIONS: DPP4 is increased in papillary thyroid cancer, however, its diagnostic usefulness as a single PTC marker is doubtful.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17091451

Source DB:  PubMed          Journal:  Endokrynol Pol        ISSN: 0423-104X            Impact factor:   1.582


  6 in total

1.  INTEGRATING CLINICAL LABORATORY MEASURES AND ICD-9 CODE DIAGNOSES IN PHENOME-WIDE ASSOCIATION STUDIES.

Authors:  Anurag Verma; Joseph B Leader; Shefali S Verma; Alex Frase; John Wallace; Scott Dudek; Daniel R Lavage; Cristopher V Van Hout; Frederick E Dewey; John Penn; Alex Lopez; John D Overton; David J Carey; David H Ledbetter; H Lester Kirchner; Marylyn D Ritchie; Sarah A Pendergrass
Journal:  Pac Symp Biocomput       Date:  2016

2.  Identification of genes differentially expressed in benign versus malignant thyroid tumors.

Authors:  Nijaguna B Prasad; Helina Somervell; Ralph P Tufano; Alan P B Dackiw; Michael R Marohn; Joseph A Califano; Yongchun Wang; William H Westra; Douglas P Clark; Christopher B Umbricht; Steven K Libutti; Martha A Zeiger
Journal:  Clin Cancer Res       Date:  2008-06-01       Impact factor: 12.531

3.  A multi-gene approach to differentiate papillary thyroid carcinoma from benign lesions: gene selection using support vector machines with bootstrapping.

Authors:  Krzysztof Fujarewicz; Michal Jarzab; Markus Eszlinger; Knut Krohn; Ralf Paschke; Małgorzata Oczko-Wojciechowska; Małgorzata Wiench; Aleksandra Kukulska; Barbara Jarzab; Andrzej Swierniak
Journal:  Endocr Relat Cancer       Date:  2007-09       Impact factor: 5.678

4.  DPP4 gene silencing inhibits proliferation and epithelial-mesenchymal transition of papillary thyroid carcinoma cells through suppression of the MAPK pathway.

Authors:  X Hu; S Chen; C Xie; Z Li; Z Wu; Z You
Journal:  J Endocrinol Invest       Date:  2021-01-02       Impact factor: 4.256

5.  Integrated analysis of fine-needle-aspiration cystic fluid proteome, cancer cell secretome, and public transcriptome datasets for papillary thyroid cancer biomarker discovery.

Authors:  Chia-Chun Wu; Jen-Der Lin; Jeng-Ting Chen; Chih-Min Chang; Hsiao-Fen Weng; Chuen Hsueh; Hui-Ping Chien; Jau-Song Yu
Journal:  Oncotarget       Date:  2018-01-04

6.  A new ferroptosis-related gene model for prognostic prediction of papillary thyroid carcinoma.

Authors:  Xiaoyu Qian; Jian Tang; Lin Li; Ziqiang Chen; Liang Chen; Yongquan Chu
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.